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Abstract
Adeno-associated viral (AAV) vectors are characterised by low immunogenicity, although
humoral and cellular responses may be triggered upon infection. Following systemic admin-
istration high levels of vector particles accumulate within the liver. Kupffer cells (KCs) are
liver resident macrophages and an important part of the liver innate immune system.
Decreased functional activity of KCs can contribute to exaggerated inflammatory response
upon antigen exposure. Heme oxygenase-1 (HO-1) deficiency is associated with consider-
ably reduced numbers of KCs. In this study we aimed to investigate the inflammatory
responses in liver and to characterise two populations of hepatic macrophages in adult wild
type (WT) and HO-1 knockout (KO) mice following systemic administration of one or two
doses (separated by 3 months) of self-complementary (sc)AAV9 vectors. At steady state,
the livers of HO-1 KO mice contained significantly higher numbers of monocyte-derived
macrophages (MDMs), but significantly less KCs than their WT littermates. Three days after
re-administration of scAAV9 we observed increased mRNA level of monocyte chemoattrac-
tant protein-1 (Mcp-1) in the livers of both WT and HO-1 KO mice, but the protein level and
the macrophage infiltration were not affected. Three days after the 1st and 3 days after the
2nd vector dose the numbers of AAV genomes in the liver were comparable between both
genotypes indicating similar transduction efficiency, but the percentage of transgene-
expressing MDMs and KCs was higher in WT than in HO-1 KO mice. In the primary culture,
KCs were able to internalize AAV9 particles without induction of TLR9-mediated immune
responses, but no transgene expression was observed. In conclusion, in vivo and in vitro
cultured KCs have different susceptibility to scAAV9 vectors. Regardless of the presence or
absence of HO-1 and initial numbers of KCs in the liver, scAAV9 exhibits a low potential to
stimulate inflammatory response at the analysed time points.
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Introduction
Recombinant adeno-associated viral (AAV) vectors, derived from a replication-defective, non-
pathogenic parvovirus with a small single-stranded (ss) DNA genome, have emerged as an
attractive gene therapy tool due to safe, stable and long-term transgene expression. The
genome of the recombinant AAV vectors, in contrary to the genome of the wild type virus,
does not undergo site-specific integration into the host DNA but mainly remains in the
episomal form in the nuclei of transduced cells [1]. Following cellular entry and translocation
to the nucleus, ssAAV genome must be converted to a double-stranded (ds) form to enable
transgene expression. This rate-limiting step in AAV transduction is omitted when the self-
complementary (sc) AAV vectors, developed by the elimination of a nicking site in one of the
inverted terminal repeats (ITRs) [2], are used. AAV vectors generated from several naturally
occurring AAV serotypes have different cell tropism and kinetics of transgene expression
(reviewed in: [1]). Their ability to efficiently transduce terminally differentiated or non-prolif-
erating cells provides considerable, long-term in vivo gene transfer in various cell types e.g.
muscle cells, hepatocytes, neurons, retinal cells, and many others (reviewed in: [1]). Several
AAV serotypes are capable of body-wide transduction after a single intravascular injection [3–
5], even though in certain diseases, utilisation of more selective serotypes might be beneficial.
For example, in patients suffering from Duchenne muscular dystrophy the application of AAV
serotype 9 (AAV9), which enables high and long-term transgene expression in the heart and
skeletal muscles [5, 6], may be advantageous. At the same time, however, systemic delivery of
AAV9 results in liver transduction [5].
Apart from its crucial role in metabolism, liver plays an important role in the systemic
immune response [7]. The organ relies on its own immune system consisting of macrophages,
natural killer cells and T cells [8], to protect itself from damage due to different pathogens and
toxic agents that enter the liver via the portal vein or hepatic artery. On the other hand, this
uniquely specialised immune system of the liver, conferring the so-called immunotolerance,
ensures that the liver does not mount a strong immune response against harmless self, dietary,
and commensal organism antigens that arrive from the circulation via the hepatic artery and
from the gastrointestinal tract via the portal vein. Hepatic macrophages are defined as a het-
erogeneous population of immune cells derived either from circulating monocytes or from
fetal yolk sac and local precursors [9]. The first population, in mice called Ly6Chi monocyte-
derived macrophages (MDMs), is massively recruited from the bloodstream to the injured
liver and is linked to chronic inflammation and fibrosis [9]. The latter population consists of
Kupffer cells (KCs) and is maintained through self-renewing divisions [10, 11]. Importantly,
recent studies demonstrate that following depletion of liver-resident KCs, circulating mono-
cytes engraft in the emptied niches of the liver and gradually become long-lived self-renewing
cells [12, 13]. KCs are predominantly localized in the hepatic sinusoids what enables a direct
contact with blood-derived leukocytes and facilitates the clearance of pathogens entering the
liver with blood. As such, KCs have been implicated in both immunogenic and tolerogenic
immune reactions [14–16].
AAV vectors can activate innate immune response due to interaction with Toll-like recep-
tors (TLRs), either through capsid or viral genome recognition by TLR-2 and TLR-9, respec-
tively. This leads to NFκB-mediated upregulation of proinflammatory cytokines such as tumor
necrosis factor α (TNFα), interleukin (IL)-6, IL-8 and several components of the IL-1 pathway
[17–19]. However, it has been shown that activation of such response in vivo is transient, self-
limited and resolved within several hours after vector administration [17, 20]. In general, AAV
vectors are characterised by low immunogenicity, although humoral as well as T cell responses
in patients may be induced [21, 22]. Exposure to wild-type AAV or systemic administration of
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the AAV vector leads to the generation of circulating antibodies directed against the AAV cap-
sid [21, 22]. Binding of neutralizing antibodies (nAbs), targeting viral epitopes critical for cel-
lular entry or vector disassembly, to the capsid limits infectivity of the viral vector and may
have a profound effect on gene transfer efficiency [23, 24]. The use of alternate capsids,
immune suppression and decoy capsid approaches partially solved this serious problem in the
gene therapy field [25]. As susceptibility of AAV vectors to nAbs can vary depending on vari-
ous, yet not completely understood factors, the presence of pre-existing antibodies may not
necessarily exclude subjects from a particular gene therapy. For example a recent study by
Majowicz et al shows that hemophilia B patients can be successfully treated by systemic admin-
istration of AAV5-based vectors in the presence of detectable pre-existing anti-AAV5 nAbs
[26].
Heme oxygenase-1 (HO-1, HMOX1) catalyzes conversion of heme to biliverdin, carbon
monoxide (CO), and ferrous iron (Fe2+). Through the first two compounds and upregulation
of ferritin by iron ions, HO-1 exerts cytoprotective and immunomodulatory effects [27].
Indeed, this protein has been shown to regulate both innate and adaptive immune responses
[28]. Moreover, HO-1 knockout (KO) mice were previously characterized by enhanced liver
inflammation and considerably reduced numbers of KCs due to toxicity of the accumulated
heme following phagocytosis of senescent red blood cells [29]. It was also shown that liver
macrophages in HO-1 KO mice present a pro-inflammatory and activated phenotype [30]. So
far, there have only been two human cases of HO-1 deficiency described [31, 32], but the mag-
nitude of HO-1 expression may be influenced by polymorphisms in the HMOX1 gene pro-
moter [33, 34]. Increased monocytic HMOX1 expression was associated with reduced markers
of inflammatory polarization [35].
The aim of this study was to investigate the inflammatory responses in liver and to charac-
terise two populations of hepatic macrophages following systemic injection of scAAV9 vectors
in wild type (WT) and HO-1 KO mice, the latter characterised by significantly reduced Kupf-
fer cell numbers. To promote the in vivo response to AAVs, we administered intravenously
two doses (separated by 3 months) of either an empty vector (without transgene-coding
sequence) or a vector carrying a reporter gene—green fluorescent protein (GFP). The classical
animal models to study the impact of pre-existing immunity are based on vector re-adminis-
tration 4 weeks after the first injection [36]. However, administration of the 2nd dose of vector
3 months after the 1st one, should be more clinically relevant. In this case, very high anti-AAV
antibody titers, which presumably would only be seen in humans after a recent exposure [21],
can be avoided. On the 3rd day after delivery of the second dose of scAAV9 we observed
increased monocyte chemoattractant protein-1 (Mcp-1) mRNA level in the livers of both WT
and HO-1 KO mice, but the protein level and the macrophage infiltration were not affected.
Plasma samples collected 3 days after vector re-administration demonstrated considerable and
significantly higher in HO-1 KO than in WT mice in vitro neutralizing activity to AAV9. In
addition, a robust transgene expression in the two analyzed populations of hepatic macro-
phages was observed with the higher numbers of transgene-expressing cells in WT than in
HO-1 KO mice. In the primary culture, KCs were able to internalize AAV9 without induction
of TLR9-mediated immune responses. However, in contrast to the animal studies, no trans-
gene expression was observed in the cultured KCs.
Materials and methods
AAV production
Production of scAAV9 vectors was performed using CellRoll Bottle Roller (Integra) in three-
plasmid Helper-free system. Briefly, HEK293 cells were seeded on collagen-coated polystyrene
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Roller Bottles (Corning), cultured until they reached 50–60% confluence and co-transfected
with 130 μg of pHelper, 100 μg of p5E18VD2/9 and 90 μg of pdAAV-CMV-Empty (containing
CMV promoter, but devoid of transgene-coding sequence) or pdAAV-CMV-GFP plasmids,
using polyethylenimine (linear, MW 25000, Polysciences) as a transfection reagent (2.58 mg/
ml; 1 μl per 1 μg of DNA). After 72 hours, cells were detached from the culture surface, centri-
fuged (10 min, 350×g), washed in PBS and resuspended in a small volume of PBS containing
calcium and magnesium. Then, the cells were lysed by 3 cycles of freezing in liquid nitrogen
and thawing in 37˚C water bath with vigorous mixing after each cycle. The lysate was digested
with HS nuclease (MoBiTec) in final concentration of 50 U/ml for 1 hour at 37˚C. Next, lysates
were cleared twice through centrifugation, each for 30 min at 4000×g at 4˚C and subsequently
subjected to purification by ultracentrifugation on discontinuous iodixanol density gradient.
The gradient was built of processed crude lysate placed on 15%, 25%, 40% and 54% iodixanol
layers. Iodixanol dilutions were prepared in PBS with 0.5 mM MgCl2 and 2.5 mM KCl. After 2
hours of centrifugation in angular rotor at 300 000×g, 18˚C, AAV-containing fraction (40%)
was collected with a needle and syringe and subjected to concentration procedure on Ami-
con1Ultra-15 Centifugal Filters (100 kDa, Merck Millipore). Quantitative PCR-based titra-
tion of AAV genome copies in isolated DNA was performed with ITR-binding TaqMan probe
and TaqMan Gene Expression Master Mix, according to manufacturer’s instructions. Final
concentration of specific primers and TaqMan probe equalled to 100 nM (For: 5’-CGG CCT
CAG TGA GCG A-3; Rev: 5’-GGA ACC CCT AGT GAT GGA GTT-3’; probe: 5’-6-
FAM-CAC TCC CTC TCT GCG CGC TCG-BHQ-1-3’).
Animal procedures
All animal procedures were in accordance with Guide for the Care and Use of Laboratory Ani-
mals (Directive 2010/63/EU of European Parliament) and carried out under a license from the
Ethical Committee of the Jagiellonian University (approval number: 64/2013). In all the exper-
iments we used 3-4-months-old females of C57BL/6×FVB background, wild type (WT) or
heme oxygenase-1 knock-out (HO-1 KO) specific pathogen free (SPF) mice. Mice had access
to food and water ad libitum. Before AAV administration, mice were anesthetized with 5% iso-
flurane. During AAV injection isoflurane was reduced to 1.5–2%. The limb withdrawal
response to toe pinch was monitored to ensure the adequacy of anesthesia. In all, 5×1011 vector
genome (vg) equivalents of scAAV9 vectors were injected into the jugular vein of WT and
HO-1 KO mice as 150 μl bolus using a sterile syringe and 29G needle. Three days post-1st
injection, part of the animals was euthanized and peripheral blood and liver samples were col-
lected for further analysis. Three months after the 1st vector administration another group of
mice received the 2nd dose of scAAV9 (1×1011 vg/mouse). Three days after the 2nd vector dose
the animals were euthanized and peripheral blood and liver samples were collected for further
analysis.
In the end of the experiment, mice were injected intraperitoneally with a mixture of keta-
mine hydrochloride (200 mg/kg) and xylazine hydrochloride (40 mg/kg). Then, blood was col-
lected by cardiac puncture using a 22G needle and syringe containing heparin as an
anticoagulant (final concentration: 10 U/ml of blood). Subsequently, the liver was perfused in
situ with 5 ml PBS containing 0.5 U/ml heparin via left ventricle punctured with PE-50 cathe-
ter connected to a perfusion apparatus (3 ml/minute flow rate). Each liver tissue was divided
into several pieces used directly in flow cytometry or stored frozen in −80˚C for RNA, DNA or
protein analysis. For histological analyses, one piece of each tissue was embedded in paraffin
and another one in tissue freezing medium. Blood samples were centrifuged (800×g, 10 min,
4˚C) and the collected plasma was transferred to new tube and stored frozen at −80˚C.
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Immunophenotyping of liver macrophages using flow cytometry
For preparation of a single cell suspension liver was excised, placed in saline on ice, finely
minced with surgical scissors and finally incubated in a mixture of 5 mg/ml of collagenase type
II (Gibco) and 1.2 U/ml of dispase (Gibco) in PBS with calcium and magnesium ions (Lonza)
for 1 hour at 37˚C with gentle agitation. Then, equal volume of Dulbecco’s Modified Eagle’s
Medium with 4.5 g/l glucose (DMEM HG; Lonza) supplemented with 10% Fetal Bovine
Serum (FBS; Gibco) was added. Dissociated cells and undigested tissue were centrifuged at
200×g for 5 minutes and the pellet was resuspended in 5 ml of PBS (Lonza). Cell/tissue suspen-
sion was passed through 40 μm filters, centrifuged and resuspended in PBS until further analy-
sis. Before staining, the single cell suspension was incubated for 10 minutes on ice with Fc
receptor Blocking Reagent (Miltenyi Biotec) in PBS supplemented with 2% FBS. Then, the
cells were incubated for 30 minutes at 4˚C with the following antibody mix: BV605-conjugated
rat anti-mouse CD45 (clone: 30-F11; BD Biosciences), AF700-conjugated rat anti-mouse
CD11c (Clone: N418, BD Biosciences); APC-Cy7-conjugated rat anti-mouse CD11b (Clone:
M1/70, BD Biosciences) and APC-conjugated rat anti-mouse F4/80 (Clone: BM8, BD Biosci-
ences). DAPI was used for the exclusion of nonviable cells. The cells were washed with PBS
and analyzed using LSRFortessa cytometer (BD Biosciences) and FacsDiva (BD Biosciences)
or FlowJo 10 (FlowJo, LLC) Software. Unstained, single stained, and fluorescence-minus-one
(FMO) controls were used for setting compensation and gates.
RNA isolation and quantitative PCR
Liver fragments were collected, snap-frozen in liquid nitrogen and stored at −80˚C. Total
RNA was isolated through modified phenol-chloroform extraction, followed by isopropanol
precipitation. Lysis of the tissue was performed using Tissue Lyzer (Qiagen) in 1 ml of Qiazol
(Qiagen) reagent. In case of in vitro cultured Kupffer cells, RNA isolation was carried out
using Single Cell RNA purification Kit (NORGEN). Concentration and quality of the RNA
was determined through absorbance measurement at 230, 260 and 280 nm utilizing Nano-
Drop1000 Spectrophotometer (Thermo Fisher Scientific). Synthesis of cDNA was performed
with RevertAid reverse transcriptase (Thermo Fisher Scientific) from 1 μg of liver RNA or
with High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) from KCs RNA.
Obtained cDNA was diluted to the final concentration of 10 ng/μl in nuclease-free water.
Quantitative PCR (qPCR) was performed using StepOne Plus Real-Time PCR (Applied Bio-
systems) with reaction mix composed of SYBR Green PCR Master Mix (SYBR1 Green Jump-
Start™ Taq, Sigma), 20 ng of a template and specific primers (final 500 nM; Table 1).
Elongation factor 2 (Eef2) served as a housekeeping gene in the mRNA analyses. Results and
product melt curves were analysed using software provided by the manufacturer.
DNA isolation and quantification of AAV genome copies
Liver fragments were collected, snap-frozen in liquid nitrogen and stored at -80˚C. For quanti-
fication of AAV genomes, DNA was isolated using phenol-chloroform-isoamyl alcohol extrac-
tion method. First, liver fragments were homogenized using Tissue Lyzer in lysis buffer (10
mM EDTA, 1% SDS and 400 μg/mL Proteinase K in volume of 500 μl adjusted with tris buff-
ered saline) and incubated for 1 hour at 37˚C to disintegrate the tissue. Obtained solution was
later combined with equal volume of phenol-chloroform-isoamyl alcohol (25:24:1, Sigma-
Aldrich) and mixed vigorously for 1 minute and then centrifuged for 10 minutes at 12 000×g.
Top, aqueous phase was collected to fresh tubes and 10 μl of 5 M NaCl and 1 ml of absolute
ethanol were added. Then, samples were left at -20˚C overnight for precipitation. The follow-
ing day, after 15 minutes of centrifugation at 12 000×g, DNA pellet was washed once with 70%
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ethanol, dried and resuspended in ultrapure water. AAV genome copies were quantified with
qPCR using ITR-binding TaqMan probe, as in case of titration procedure.
Immunofluorescence
For immunofluorescent detection of macrophages liver sections were stained against F4/80
and CD11b antigens. Paraffin-embedded liver sections were deparaffinized and subjected to
antigen retrieval using 0.05 M sodium citrate buffer (pH 6.0) in microwave oven. Tissues were
washed in PBS and blocked in a solution containing 10% goat serum. After blocking, tissue
sections were incubated with primary rat antibodies recognizing mouse F4/80 antigen (dilu-
tion 1:200, overnight at 4˚C; clone: BM8; eBioscience) followed by fluorochrome-conjugated
secondary anti-rat antibody (Alexa Fluor 488; dilution 1:400, 1 hour 30 minutes at RT). Liver
cryosections were incubated with rat anti-mouse CD11b antibody (dilution 1:200, overnight,
4˚C; clone: 5C6; Bio-Rad) followed by fluorochrome-conjugated secondary anti-rat antibody
(Alexa Fluor 488; dilution 1:400, 1 hour 30 minutes at RT). All sections were mounted with
fluorescence mounting medium (Dako) and analyzed with a fluorescent microscope (Nikon)
at 400× magnification.
Analysis of inflammatory cytokines with FlexMap3D Luminex system
Liver fragments were homogenized in lysis buffer (50mM Tris-HCl pH 8.0, 150 mM NaCl, 1%
NP-40, 0.5% Na-deoxycholate, 0.1% SDS) with protease inhibitors (cOmplete™ EDTA-free
Protease Inhibitor Cocktail, Roche) using Tissue Lyzer (Qiagen). The samples were incubated
on ice for 5 minutes and cleared by centrifugation (12 000×g, 10 minutes, 4˚C). The superna-
tant was collected and stored in -80˚C. Analysis was performed using Mouse Cytokine Mag-
netic 10-Plex Panel (Invitrogen) according to the manufacturer’s instructions. The results
were analyzed with FLEXMAP 3D xPONENT software.
ELISA
The content of mouse IL-6 in plasma was evaluated according to vendor’s protocol.
Table 1. List of specific primer pairs.
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Determination of AAV neutralizing antibodies (transduction-based assay)
Plasma samples collected from mice were first incubated for 30 minutes at 56˚C to inactivate
components of the complement system that may interfere with the assay. Then, serial dilutions
(2, 4, 8, 16 for one dose of AAV vectors; 20, 40, 80, 160 and 800 for two doses of AAVs) of
plasma in FBS were prepared in a final volume of 20 μl. Next, 1 μl of 1×109 AAV particles was
added to each sample and such mixture was incubated for 3 hours at 37˚C to allow binding of
the antibodies to AAV capsids. In case of a positive control, vectors were preincubated with
FBS only. Subsequently, neutralized vectors were used for transduction of 1×105 HEK293 at
the time of seeding the cells on 24-well plates. Transgene expression was analyzed after 96
hours using flow cytometer. Briefly, cells were washed once with PBS and detached from the
culture surface with 0.05% trypsin solution (Gibco). Next, 1 ml of DMEM HG supplemented
with 10% FBS was added and cells were centrifuged for 5 minutes at 350×g. Pellet was resus-
pended in PBS with 2 mM EDTA and 0.2 μg/ml DAPI to exclude nonviable cells from further
analysis with LSRFortessa cytometer.
Isolation and purification of KCs
KCs were isolated and purified according to the method described previously [37]. Mice were
subjected to pharmacological euthanasia through intraperitoneal administration of a mixture
of ketamine hydrochloride (200 mg/kg) and xylazine hydrochloride (40 mg/kg). Then, liver
was perfused in situ through left ventricle punctured with PE-50 catheter connected to a perfu-
sion apparatus (3 ml/minute flow rate) with 10 ml of 0.5 U/ml heparin in PBS without calcium
and magnesium ions and subsequently with 10 ml of 0.1% collagenase type IV in HBSS buffer.
Afterwards, the liver was excised, transferred to collagenase solution and after disruption of
Glisson’s capsule it was cut into smaller pieces to allow more efficient tissue digestion. Samples
were incubated for 10 min at 37˚C and then for 1 hour at 25˚C. Obtained suspension was
passed through 100 μm nylon strainer and centrifuged for 5 minutes at 300×g. Cells were
washed once with PBS and resuspended in RPMI medium. Next, differential centrifugation (3
minutes, 50×g, 4˚C) was performed in order to separate parenchymal cells from KCs. After
centrifugation KCs were present in the supernatant, while parenchymal fraction was in the pel-
let. KCs were further purified though selective adhesion, where unattached cells were removed
from the culture 2 hours after seeding. Primary culture of KCs was maintained in DMEM HG
supplemented with 10% FBS and antibiotics.
Stimulation of KCs with TLR9 ligand
KCs were stimulated with 5 μM class A CpG oligonucleotide (ODN 1585, InvivoGen) in
DMEM HG supplemented with 10% FBS and antibiotics. After 24 hours cells were collected
for RNA isolation and gene expression analysis.
Confocal microscopy for detection of AAV9 in KCs
KCs were seeded on glass culture surface and 24 hours later exposed to scAAV9-empty vectors
at a multiplicity of infection (MOI) of 104 viral genomes (vg)/cell. Next, after 1 hour of incuba-
tion at 37˚C and subsequent incubation for 1 hour at 4˚C, cells were fixed with 4% paraformal-
dehyde, washed with PBS and permeabilized with 0.1% Triton X-100. In the next step, to
reduce non-specific antibody binding, blocking buffer (5% BSA, 0.5% Tween 20, 10% goat
serum in PBS) was added for 1 hour at room temperature and subsequently, it was replaced
with mouse anti-AAV9 antibody (ADK9, Progen) diluted 10 times in PBS containing 0.5%
BSA, 0.05% Tween 20 and 1% goat serum for 2 hours at RT. Then, cells were washed with PBS
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and incubated with fluorochrome-conjugated goat anti-mouse IgG, IgM, IgA secondary anti-
body (AlexaFluor 488; dilution 1:200, 1 hour at RT). Slides were sealed with mounting
medium containing DAPI and analyzed with Leica TCS SP5 II microscope together with LAS
AF software (Leica Microsystems).
Statistical analysis
Results are presented as mean value ± SEM, unless otherwise stated. Statistical analyses were
carried out using GraphPad Prism software version 6 (GraphPad Software, Inc.). For two-
group comparisons, Mann-Whitney U test was applied. For comparing more than two groups,
a one-way ANOVA followed by Tukey’s post hoc test was applied. For � p>0.05, for �� p>0.01
and for ��� p>0.001.
Results
Hepatic expression of Mcp-1 is significantly affected by the lack of HO-1,
but not much changed upon scAAV9 vectors delivery
It was previously shown that scAAV vectors are capable of inducing TLR9-mediated increase
in the expression of IFNα/β, MCP-1, TNF-α, and other proinflammatory cytokines and che-
mokines in the liver [17]. However, such innate immune response to scAAV was self-limited
and resolved within less than 12 hours after vector administration [17]. In relation to the onset
of transgene expression from scAAV vectors [2] and temporal kinetics of monocyte/macro-
phage infiltration in response to a potential damaging stimuli [38], our analyses were per-
formed 3 days after the 1st and 2nd vector dose. We observed slight (about 2 times)
upregulation of Mcp-1 expression in the livers of WT mice 3 days post-1st injection of both
(empty and GFP-expressing) scAAV9 vectors (Fig 1A). Regardless of the treatment, Mcp-1
expression in the livers of HO-1 KO mice was markedly higher than in WT mice (Fig 1A).
Moreover, higher expression of Mcp-1 was detected in HO-1 KO mice injected with one dose
of scAAV9-GFP when compared to untreated control or scAAV9-empty vector (Fig 1A). The
induction of Mcp-1 in WT mice 3 days after the 2nd dose of scAAV9-empty or scAAV9-GFP
was even more pronounced than after the 1st vector dose (5-fold and 7-fold change, respec-
tively) when compared to untreated control (Fig 1B). In HO-1 KO mice we also observed
induction of Mcp-1 expression 3 days after re-administration of either scAAV9-empty or
scAAV9-GFP (6-fold and 3-fold change, respectively) when compared to untreated controls
(Fig 1B). MCP-1 protein level was higher in the livers of HO-1 KO than of WT mice (Fig 1C)
and there was a slight, but statistically not significant increase in MCP-1 protein level in HO-1
KO mice 3 days after re-administration of either scAAV9-empty or scAAV9-GFP as compared
to untreated HO-1 KO control (Fig 1C).
The expression of Tnfα was considerably higher in the liver of HO-1 KO than of WT mice,
but in both genotypes there were no differences after one or two doses of scAAV9 vectors
when compared to untreated control (Fig 1D and 1E). In both genotypes the TNFα protein
levels also remained unchanged after scAAV9 vector delivery (Fig 1F). Hepatic expression of
other analyzed cytokines (IL-1β, IL-10, IL-6, IL-12, IL-17, IFNα/β, IFNγ, MIP-1α) did not dif-
fer between both genotypes and treatments (not shown).
Phenotypic analysis of hepatic macrophages reveals differences between
WT and HO-1 KO mice
In healthy adult mice KCs represent about 35% of the non-parenchymal liver cells [39]. Their
specific localization and the fact that they constitute 80–90% of tissue macrophages present in
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the body suggest a central role of the liver in systemic and local defence [39]. It was previously
shown that in the absence of HO-1 KCs die following phagocytosis of senescent red blood cells
due to toxicity of the accumulated heme [29]. Our immunohistochemical analysis revealed
that the frequency of F4/80 expressing cells in the liver of HO-1 KO mice is lower than in WT
mice (Fig 2; left panel). On the other hand, the liver of HO-1 KO mice contained higher num-
ber of CD11b-positive cells when compared to WT mice (Fig 2; right panel), what is in line
with previous observation [30]. KCs identification is based mainly on the expression of F4/80
marker, sometimes combined with CD11b and/or CD68 [40]. More recently, flow cytometric
analysis by Movita et al. defined two populations of hepatic macrophages: F4/80low CD11bhigh
(MDMs) and F4/80high CD11blow (KCs) [41]. We applied similar strategy to quantitatively
analyze the numbers of these cells in the livers of WT and HO-1 KO mice (Fig 3A). We found
that the frequency of KCs in adult untreated WT mice is about 7% of the CD45+ leukocytes
(Fig 3B). Independently of the treatment, the number of KCs were several times higher in WT
than in HO-1 KO mice and only in case of WT mice their number significantly increased 3
days after delivery of the 1st dose, but not after the 2nd injection of scAAV9-GFP (Fig 3B). On
the contrary, the livers of adult HO-1 KO mice contained several times more MDMs than
their WT littermates (Fig 3C), and only in HO-1 KO mice this population expanded 3 days
after the 1st, but not after the 2nd dose of scAAV9-GFP (Fig 3C). These data indicate a lack of
considerable macrophage infiltration into the liver upon scAAV9 re-administration indepen-
dently of the initial liver KC/MDM numbers.
Fig 1. Hepatic expression of inflammatory genes in WT and HO-1 KO mice after scAAV9 vectors injection. (A) The qPCR
for Mcp-1 3 days post-1st injection of scAAV9 vectors. (B) The qPCR for Mcp-1 3 days after scAAV9 re-administration. (C) The
Luminex assay for MCP-1 protein 3 days after scAAV9 re-administration. (D) The qPCR for Tnfa 3 days post-1st injection of
scAAV9 vectors. (E) The qPCR for Tnfa 3 days after scAAV9 re-administration. (F) The Luminex assay for TNFα protein 3 days
after scAAV9 re-administration. Values represent means ± SEM (n = 3-4/group). p<0.05 � vs. appropriate WT, † vs. appropriate
untreated, $ vs. appropriate scAAV-empty.
https://doi.org/10.1371/journal.pone.0240691.g001
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Lack of HO-1 results in higher AAV9 neutralizing activity and lower
transgene expression in two populations of liver macrophages
The in vitro neutralization assay revealed that inhibition of HEK293 transduction with plasma
samples collected 3 days post-1st injection of scAAV9-GFP was very limited, without significant
differences between WT and HO-1 KO mice (Fig 4A). In another experiment using different
control scAAV9 vector (without GFP expression), we observed several times higher and compa-
rable between both genotypes neutralizing activity of the plasma collected 14 days after the 1st
vector dose (not shown). After re-administration of scAAV9-GFP we still detected very effective
inhibition of HEK293 cells transduction confirming efficient generation of nAbs to AAV9 vec-
tors (Fig 4A). Interestingly, this time stronger inhibitory effect was observed in HO-1 KO indi-
viduals–comparable transduction efficiency was achieved for 160-times diluted plasma of WT
and 800-times diluted plasma of HO-1 KO mice, indicating about 5 times higher neutralizing
activity of HO-1 KO mice-derived plasma (Fig 4A). Humoral immunity to AAV vectors was
recently associated with increased secretion of IL-1β and IL-6 cytokines by monocyte-related
dendritic cells [42]. Here, we found considerably higher level of IL-6 in the plasma of HO-1 KO
when compared to WT mice following exposure to the 2nd dose of AAV9 (S1 Fig).
Three days after vector re-administration, the livers of WT mice contained significantly
more GFP-positive KCs (Fig 4B) and MDMs (Fig 4C) than the livers of HO-1 KO mice. Simi-
larly, 3 days after vector re-administration the percentage of GFP-positive cells within a heter-
ogenous population of CD45-negative liver cells was about 2 times higher in WT than in HO-
1 KO mice (not shown). Different numbers of GFP-expressing macrophages in WT and HO-1
KO mice could not be explained by differences in availability of AAV9 primary receptor (the
Fig 2. Immunofluorescent staining of macrophages in the livers of WT and HO-1 KO mice. Representative
fluorescent images of F4/80 marker (green, left panel). Representative fluorescent images of CD11b marker (green,
right panel). Scale bar = 100 μm.
https://doi.org/10.1371/journal.pone.0240691.g002
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terminal galactose in N-linked glycans) [43]. The staining of both populations of hepatic mac-
rophages with Maackia Amurensis lectin-II (MAL-II; binds sialic acid attached to terminal
galactose in α-2,3 linkage) or with Sambucus Nigra agglutinin (SNA; binds sialic acid attached
to terminal galactose in α-2,6 linkage) resulted in comparable fluorescence intensity (S2 and
S3 Figs, respectively). Moreover, after the 1st as well as after the 2nd vector dose we detected
comparable numbers of AAV genomes in the livers of WT and HO-1 KO mice (Fig 4D) indi-
cating similar transduction efficiency between genotypes.
AAV9 infects the primary culture of Kupffer cells without triggering
TLR9-mediated immune responses, but does not lead to transgene
expression
Due to specific localization and function in the liver, Kupffer cells are indispensable for organ’s
response to foreign agents, such as bacteria or viruses [39]. Thus, in order to more deeply
Fig 3. Flow cytometric analysis of two populations of hepatic macrophages in WT and HO-1 KO mice after
scAAV9 vectors injection. (A) Gating strategy and representative dot plots demonstrating F4/80lowCD11bhigh
(MDMs) and F4/80highCD11blow (KCs). Flow cytometric analysis of KCs (B) and MDMs (C) 3 days after first and 3
days after second administration of scAAV9 vectors. Values represent means ± SEM (n = 3–4 mice/group). �p< 0.05
vs. appropriate WT; † p< 0.05 vs. appropriate untreated; # p< 0.05 vs. AAV9-GFP after the 1st administration.
https://doi.org/10.1371/journal.pone.0240691.g003
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investigate their potential responses to scAAV9 vectors, we isolated and purified the cells
according to the previously described method [37]. First, the cells were subjected to two func-
tional tests: uptake of DiI-labelled acetylated low-density lipoproteins (DiI-AcLDL) and pro-
duction of inflammatory cytokine TNFα in response to LPS. The internalization of
fluorescently-labelled AcLDL, which in macrophages is driven by a family of scavenger recep-
tors (SRs), including SR-A, SR-B1, and CD36 [44], was visible as early as 1 hour after addition
to the cell culture media (Fig 5A, left panel) and after 16 hours nearly all cells exhibited strong
fluorescence (Fig 5A, right panel). Next, KCs were stimulated for 1 or 21 hours with different
concentrations of bacterial endotoxin (LPS). At both time-points we have observed LPS-
induced production of TNFα (Fig 5B). These results demonstrated that, in line with previous
observations [37], the isolated cells had ability to uptake the modified AcLDL and to produce
Fig 4. Plasma neutralizing activity and transgene expression in liver macrophages after scAAV9-GFP transduction.
(A) Virus neutralization test in plasma samples collected from WT and HO-1 KO mice 3 days after the 1st administration
and 3 days after the 2nd administration of scAAV9-GFP. Flow cytometric analysis of GFP-positive (GFP+) KCs (B) and
MDMs (C) in the livers of WT and HO-1 KO mice 3 days after the 1st administration and 3 days after the 2nd
administration of scAAV9-GFP. (D) The qPCR assessing the number of vector genomes in the livers of WT and HO-1 KO
mice 3 days after the 1st administration and 3 days after the 2nd administration of scAAV9-GFP. Values represent
means ± SEM (n = 3-4/group). �p< 0.05 vs. appropriate WT; † p< 0.05 vs. appropriate untreated; # p< 0.05 vs.
AAV9-GFP after the 1st administration.
https://doi.org/10.1371/journal.pone.0240691.g004
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specific inflammatory cytokine in response to LPS. Additionally, we detected increased expres-
sion of Il10 in cells stimulated with CpG ODN (Fig 5C, S4 Fig) and thus, confirmed the previ-
ous observations [41] that KCs in vitro have functional signalling in response to TLR9 agonist.
Next, we exposed these cells to scAAV9-empty (MOI 104). Already after 2 hours following
addition of scAAV9-empty to the cultured KCs, the vector particles were present in the cyto-
plasm (Fig 5D, left panel). AAV vectors were previously shown to activate inflammatory genes
in liver within 2 hours after gene transfer via NF-κB pathway and TLR2- or TLR9-mediated
recognition of capsid or vector DNA, but these innate immune responses were attenuated in
the next 12 hours [17–19]. In our cultured WT and HO-1 KO KCs the expression of genes
associated with TLR9 signalling—Tlr9, Myd88, Ifnα, Ifnβ, Tnfα and Il10 –remained unchanged
2 and 6 hours following addition of scAAV9-empty or scAAV9-GFP (Fig 6A, 6B, 6C, 6D, 6E
and 6F, respectively). Moreover, unlike the in vivo infection, GFP transgene was not expressed
in the primary culture of KCs exposed to scAAV9-GFP, as monitored up to 7 days after addi-
tion of scAAV9-GFP (MOI 104, not shown).
Discussion
Data presented here show that the exposure of mice to two doses (separated by 3 months) of
scAAV9 did not lead to a considerable increase in inflammatory cytokines expression and
Fig 5. Functional assessment of mouse KCs in culture. (A) Phase contrast and fluorescence microscopy images of
KCs fluorescently labelled with DiI-AcLDL after 1 hour and 16 hours of incubation. (B) Production of TNFα in the
supernatant of KCs stimulated with LPS for 1 hour and 21 hours in FBS-free conditions. (C) The qPCR for Il10 after 24
hours stimulation with CpG ODN 1585. (D) Confocal microscopy images demonstrating internalization of scAAV9
particles by KCs 2 hours after addition of 104 MOI of scAAV9-empty (left panel). � p< 0.05 vs. appropriate untreated
control; † p< 0.05 vs. appropriate 1 hour treatment.
https://doi.org/10.1371/journal.pone.0240691.g005
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macrophage infiltration, neither in WT nor in HO-1 KO mice. However, HO-1 deficiency was
associated with notably decreased transgene expression in two main populations of hepatic
macrophages–MDMs and KCs. In addition, KCs in culture internalized scAAV9 vectors, but
did not express the transgene and did not exhibit any signs of TLR9-mediated immune
response activation.
Application of scAAV instead of ssAAV was previously shown to cause a substantial
increase in the innate TLR9-dependent immune responses in liver independently of the strain
of mouse or the transgene/promoter cassette [17]. TLR9 is located in endosomes and recog-
nizes unmethylated cytosine-guanine dinucleotide motifs that are typically present in viral or
bacterial, but not mammalian DNA [45]. The downstream signalling, through the MyD88
adapter molecule, activates NF-κB and consequently the expression of proinflammatory cyto-
kines and induces the expression of type I interferons (IFNα and β) via IFN-regulatory factors
(IRF-3 and -7). Martino et al. demonstrated the TLR9-mediated induction of IFNα/β, MCP-1,
TNF-α, and other proinflammatory cytokines and chemokines in the liver by scAAV vectors
[17]. Importantly, the innate response to scAAV2 was self-limited and resolved within less
than 12 hours after vector administration [17]. Cells of the monocytic lineage are the primary
synthesizers of TNFα, a powerful pro-inflammatory agent that regulates many facets of
Fig 6. Expression of genes associated with TLR9 signaling in primary culture of KCs exposed to scAAV9 vectors.
The qPCR for (A) Tlr9, (B)Myd88, (C) Ifna, (D) Ifnb, (E) Tnfa and (F) Il10 at 2 and 6 hours after in vitro exposure of
WT and HO-1 KO KCs to 104 MOI of scAAV9-empty or scAAV9-GFP. � p< 0.05 vs. appropriate WT; $ p< 0.05 vs.
untreated HO-1 KO.
https://doi.org/10.1371/journal.pone.0240691.g006
PLOS ONE Inflammatory responses in liver of HO-1 deficient mice exposed to scAAV9
PLOS ONE | https://doi.org/10.1371/journal.pone.0240691 October 15, 2020 14 / 21
macrophage function [46]. In our study, the mRNA expression of this cytokine, similarly to
Mcp-1, was higher in HO-1 KO than in WT mice. Interestingly, unlike MCP-1, TNFα protein
level did not correspond with its mRNA. The high potency of TNFα in terms of protecting the
host from infection requires stringent control of this cytokine expression. An important regu-
latory checkpoint is AU-rich elements (AREs) embedded in the 30 UTR of TNFα mRNA offer-
ing protection against the overexpression [47]. Perhaps, a tight regulation of TNFα mRNA
translation might explain the observed here by us discrepancy between this cytokine mRNA
and protein level in HO-1 KO mice. In addition, unlike Mcp-1, the expression of Tnfα was
increased neither 3 days after the 1st scAAV9 dose nor 3 days upon vector re-administration.
It was previously shown that in the liver AAV-mediated induction of TNFα, as well as IL-
1β and IL-6 expression, precedes MCP-1 [48] indicating a possible mechanism of activation of
MCP-1 transcription by these cytokines [49]. MCP-1 is produced by many cell types, but
monocytes/macrophages are its major source [30, 39]. Moreover, MCP-1 is known to attract
memory T cells expressing CCR2 and influence T-cell immunity [28,35]. In the study by Mar-
tino et al. the production of MCP-1 in response to scAAV vectors was to some extent depen-
dent on KCs as inactivation of these cells with GdCl3 administration partially blocked
macrophage infiltration in the liver [17]. In our HO-1 KO mice, characterized by decreased
numbers of KCs, the expression of Mcp-1 was increased 3 days after the 2nd dose of scAAV9,
but the protein levels and abundance of macrophages were not affected. This, together with
the lack of activation of TLR9 downstream target genes, indicates the minor potential of
scAAV vectors to activate innate immune responses in the liver regardless of the initial KCs/
MDMs ratio. Still, we cannot rule out transient upregulation of proinflammatory transcripts in
the liver at earlier time points, within first hours after scAAV administration as described by
Martino et al [17]. Nevertheless, it would require further investigation since the studies pub-
lished so far focused on AAV2 serotype, which has much shorter clearance half-life than
AAV9 after intravenous administration [50]. More rapid uptake of the vector by the cells may
not only induce a stronger immune response but also contribute to different kinetics of the
whole process depending on the investigated serotype.
Under inflammatory conditions circulating bone marrow-derived monocytes contribute to
the repopulation of the emptied niches of hepatic KCs [12, 13]. Fate-mapping experiments
revealed efficient refilling starting from day 4 post-infection and a gradual differentiation of
bone marrow-derived monocytes into F4/80highCD11blow cells [13]. HO-1 deficient mice
exhibit chronic inflammation demonstrated by high peripheral white blood cell counts,
increased monocyte vascular adhesion and tissue infiltration [51, 52]. We have recently shown
higher steady-state numbers of pro-inflammatory Ly6Chi monocytes in the blood of mice lack-
ing HO-1 [53]. Moreover, after myocardial infarction the increased expression of Mcp-1 in
these animals was associated with increased infiltration of Ly6Chi monocytes into the cardiac
muscle, what resulted in adverse remodeling and significantly impaired cardiac function [53].
In the injured liver the accumulation of inflammatory Ly6Chi monocytes also depends on the
interaction of MCP-1 with its receptor CCR2 [54]. Increased level of MCP-1 in the livers of
HO-1 KO mice resulted in constant recruitment and significantly higher than in WT mice
numbers of F4/80lowCD11bhigh MDMs. It was recently shown that WT bone marrow derived
macrophages engraft in the livers of HO-1 KO mice, differentiate into KCs, and self-renew,
protecting the recipient for several weeks and potentially for a lifetime [29, 55]. In the present
study, in WT mice we noted the expansion of KCs 3 days after delivery of the 1st dose of
scAAV9-GFP (their number after the 2nd vector dose was comparable with untreated mice).
On the other hand, in the livers of HO-1 KO mice we noted the expansion of MDMs 3 days
after the 1st dose of scAAV9-GFP (their number after the 2nd vector dose was comparable with
untreated mice). Previous study demonstrated that circulating monocytes engraft in the liver
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and become long-lived self-renewing Kupffer cells [12]. Thus, it is possible that in response to
the 1st scAAV9-GFP transduction monocytes have been recruited to the liver of both WT and
HO-1 KO mice, but for example due to the niche specificity or lack of HO-1, only MDMs in
WT mice were able to differentiate towards KCs resulting in these cells expansion. Another
reason for KCs expansion in WT mice could be their local proliferation in response to
scAAV9-GFP transduction. Both hypotheses would require further investigation using specific
lineage tracing approach.
In the present study, we observed significantly higher AAV9 neutralizing activity of the
plasma of HO-1 KO than of WT mice 3 days after scAAV9-GFP re-administration. Neutraliz-
ing antibody formation can be influenced by the genetic background of the host [56]. Several
lines of evidence suggest that HO-1 exerts immunomodulatory effects not only on innate
immune responses, but also on adaptive immunity [28]. In the field of transplantation, HO-1
was shown to regulate B cell infiltration into tissues and control destructive allo-antibody
responses [52, 57]. In addition, hemophilia A patients with a higher frequency of alleles with
large (GT)n repeats (n�30) within HMOX1 promoter (associated with lesser HO-1 expression
[33, 58]), had an increased prevalence of development of inhibitory anti-factor VIII antibodies
[59]. A recent study investigating antibody formation against AAV in healthy humans found
that the AAV capsid activates IL-1β and IL-6 cytokine secretion in monocyte-related dendritic
cells and that IL-1β and IL-6 blockade inhibited the anti-capsid humoral response in vitro and
in vivo in mice [42]. The study also demonstrated that in subjects previously exposed to WT
AAV both IL-1β and IL-6 cytokines triggered the differentiation of capsid-specific memory B
cells into antibody-secreting cells and anti-capsid antibody production [42]. In our study, the
plasma level of IL-6 was considerably higher in HO-1 KO than in WT mice re-exposed to
scAAV9-GFP. Moreover, 14 days after 1st administration of scAAV9 there was no difference
in AAV9 neutralizing activity between both genotypes (not shown). This indicates that upon
re-exposure to antigen HO-1 expression may influence the AAV-nAbs production, but the
exact mechanism considering B- and T-cells function requires further exploration.
Due to their specific location, KCs are directly exposed to any pathogens entering the liver
with blood and were shown to be involved in both immunogenic and tolerogenic immune
reactions [14–16]. As soon as 3 days after the 1st scAAV9-GFP vector dose we observed a small
number of KCs (but not MDMs) expressing GFP in both WT and HO-1 KO mice. This indi-
cates that KCs were the primary cells in the liver exposed to AAVs. Apparently, 3 days after
scAAV9-GFP vector re-administration, the numbers of GFP-expressing cells within two popu-
lations of hepatic macrophages were much higher in WT than in HO-1 KO mice. The staining
of both populations of hepatic macrophages with MAL II and SNA demonstrated that the dif-
ferences in GFP expression between WT and HO-1 KO mice could not be explained by differ-
ent availability of AAV9 primary receptor (the terminal galactose in N-linked glycans) [43].
High titers of nAbs can directly contribute to the lower transgene expression. However, higher
AAV9 neutralization activity of plasma from HO-1 KO when compared to WT mice was
observed after the 2nd but not after the 1st vector dose. Moreover, a similar number of vector
genomes detected in the livers of WT and HO-1 KO mice indicates comparable transduction
efficiency in both genotypes. Thus, other factors could contribute to the decreased number of
GFP-expressing cells in HO-1 KO mice such as faster cell turnover rate or capsid-specific cyto-
toxic T lymphocyte responses [21].
In contrary, our in vitro data demonstrate lack of transgene expression in cultured KCs
exposed to AAV9-GFP. We confirmed that although vectors are taken up by the cells, trans-
gene is not expressed. A recent paper by Fitzpatrick et al. demonstrated the presence of AAV
binding antibodies (bAbs) in adult human subjects [60]. Since the non-neutralizing AAV-
bAbs can positively impact gene transfer, we wanted to assess whether they might facilitate the
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in vitro transduction of KCs (e.g. via influencing the uptake or trafficking of AAV vectors
inside the cells). For this, we pre-incubated the scAAV9-GFP vectors with mouse plasma con-
taining AAV9 antibodies, however, we still did not detect transgene expression in cultured
KCs (not shown). Thus, it seems that some other factors, apparently absent in vitro, may be
necessary for transgene expression in KCs. Upon intravenous delivery AAVs may interact
with other, apart from neutralizing or binding antibodies, blood components (i.e. galectin 3
binding protein, C-reactive protein or platelet factor-4), which can also alter the vectors’ thera-
peutic efficiencies [61]. Thus, analysis of the composition of the mouse sera would be necessary
to verify the impact of different serum proteins on KCs transduction by AAV9. The expression
of genes associated with TLR9 signalling did not differ in response to scAAV. This is in agree-
ment with other data indicating that AAVs in the liver activate rather plasmacytoid dendritic
cells (pDCs) than non-pDCs such as KCs, to produce type I interferons through the
TLR9-MyD88 pathway [18].
In summary, our data demonstrate low potential of scAAV9 to stimulate inflammatory
response at the analysed time points regardless of the presence or absence of HO-1 and initial
numbers of KCs/MDMs in the liver. On the other hand, 3 days after vector re-administration
we observed higher AAV9 neutralizing activity in plasma and significantly lower transgene
expression in hepatic macrophages of HO-1 KO mice. This suggests that different level of HO-
1 expression, in humans determined by the polymorphisms in the HMOX1 promoter, may
confer different genetic predispositions to the induction of the immune responses against
AAV vectors and in this way affect their therapeutic potential.
Supporting information
S1 Fig. Interleukin 6 in plasma of WT and HO-1 KO mice after AAV9 administration.
ELISA assessment of IL-6 in plasma collected from untreated mice, 3 days after 1st administra-
tion and 3 days after 2nd administration of scAAV9-GFP.
(TIF)
S2 Fig. Flow cytometric analysis of Maackia amurensis lectin-II binding in two populations
of hepatic macrophages in WT and HO-1 KO mice. Maackia amurensis lectin-II (MAL-II)
binds sialic acid attached to terminal galactose in α-2,3 linkage. (A) Percentage of F4/80high-
CD11blow cells labelled with MALII and (B) their median fluorescence intensity. (C) Percent-
age of F4/80lowCD11bhigh cells labelled with MALII and (D) their median fluorescence
intensity.
(TIF)
S3 Fig. Flow cytometric analysis of Sambucus nigra agglutinin binding in two populations
of hepatic macrophages in WT and HO-1 KO mice. Sambucus nigra agglutinin (SNA) binds
sialic acid attached to terminal galactose in α-2,6 linkage. (A) Percentage of F4/80highCD11blow
cells labelled with SNA and (B) their median fluorescence intensity. (C) Percentage of F4/
80lowCD11bhigh cells labelled with SNA and (D) their median fluorescence intensity.
(TIF)
S4 Fig. Expression of genes associated with TLR9 signaling in primary culture of KCs fol-
lowing stimulation with ODN. The qPCR for (A) Tlr9, (B) Myd88, (C) Tnfa, (D) Ifna, (E)
Ifnb, and (F) Il10 at 24 h after in vitro stimulation of WT and HO-1 KO KCs with ODN 1585.
�p< 0.05 vs. appropriate WT; † p< 0.05 vs. appropriate untreated.
(TIF)
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19. Hösel M, Broxtermann M, Janicki H, Esser K, Arzberger S, Hartmann P, et al. Toll-like receptor 2-medi-
ated innate immune response in human nonparenchymal liver cells toward adeno-associated viral vec-
tors. Hepatol Baltim Md. 2012 Jan; 55(1):287–97.
20. Zaiss A-K, Liu Q, Bowen GP, Wong NCW, Bartlett JS, Muruve DA. Differential activation of innate
immune responses by adenovirus and adeno-associated virus vectors. J Virol. 2002 May; 76(9):4580–
90. https://doi.org/10.1128/jvi.76.9.4580-4590.2002 PMID: 11932423
21. Mingozzi F, High KA. Immune responses to AAV in clinical trials. Curr Gene Ther. 2011 Aug; 11
(4):321–30. https://doi.org/10.2174/156652311796150354 PMID: 21557723
22. Mingozzi F, Chen Y, Edmonson SC, Zhou S, Thurlings RM, Tak PP, et al. Prevalence and pharmaco-
logical modulation of humoral immunity to AAV vectors in gene transfer to synovial tissue. Gene Ther.
2013 Apr; 20(4):417–24. https://doi.org/10.1038/gt.2012.55 PMID: 22786533
23. Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, et al. Successful transduction of liver
in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med. 2006
Mar; 12(3):342–7. https://doi.org/10.1038/nm1358 PMID: 16474400
24. Gurda BL, DiMattia MA, Miller EB, Bennett A, McKenna R, Weichert WS, et al. Capsid antibodies to dif-
ferent adeno-associated virus serotypes bind common regions. J Virol. 2013 Aug; 87(16):9111–24.
https://doi.org/10.1128/JVI.00622-13 PMID: 23760240
25. Mingozzi F, High KA. Overcoming the Host Immune Response to Adeno-Associated Virus Gene Deliv-
ery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape. Annu Rev Virol.
2017 Sep 29; 4(1):511–34. https://doi.org/10.1146/annurev-virology-101416-041936 PMID: 28961410
26. Majowicz A, Nijmeijer B, Lampen MH, Spronck L, de Haan M, Petry H, et al. Therapeutic hFIX Activity
Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-
AAV5 NABs. Mol Ther Methods Clin Dev. 2019 May 28; 14:27–36. https://doi.org/10.1016/j.omtm.
2019.05.009 PMID: 31276009
27. Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski AJ, Cisowski J, Agarwal A, et al. Heme oxyge-
nase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox
Signal. 2008 Oct; 10(10):1767–812. https://doi.org/10.1089/ars.2008.2043 PMID: 18576916
PLOS ONE Inflammatory responses in liver of HO-1 deficient mice exposed to scAAV9
PLOS ONE | https://doi.org/10.1371/journal.pone.0240691 October 15, 2020 19 / 21
28. Schumacher A, Zenclussen AC. Effects of heme oxygenase-1 on innate and adaptive immune
responses promoting pregnancy success and allograft tolerance. Front Pharmacol. 2014; 5:288.
https://doi.org/10.3389/fphar.2014.00288 PMID: 25610397
29. Kovtunovych G, Eckhaus MA, Ghosh MC, Ollivierre-Wilson H, Rouault TA. Dysfunction of the heme
recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron
distribution. Blood. 2010 Dec 23; 116(26):6054–62. https://doi.org/10.1182/blood-2010-03-272138
PMID: 20844238
30. Devey L, Ferenbach D, Mohr E, Sangster K, Bellamy CO, Hughes J, et al. Tissue-resident macro-
phages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mecha-
nism. Mol Ther J Am Soc Gene Ther. 2009 Jan; 17(1):65–72.
31. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, et al. Oxidative stress causes enhanced
endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999 Jan; 103(1):129–35.
https://doi.org/10.1172/JCI4165 PMID: 9884342
32. Radhakrishnan N, Yadav SP, Sachdeva A, Pruthi PK, Sawhney S, Piplani T, et al. Human heme oxyge-
nase-1 deficiency presenting with hemolysis, nephritis, and asplenia. J Pediatr Hematol Oncol. 2011
Jan; 33(1):74–8. https://doi.org/10.1097/MPH.0b013e3181fd2aae PMID: 21088618
33. Taha H, Skrzypek K, Guevara I, Nigisch A, Mustafa S, Grochot-Przeczek A, et al. Role of heme oxyge-
nase-1 in human endothelial cells: lesson from the promoter allelic variants. Arterioscler Thromb Vasc
Biol. 2010 Aug; 30(8):1634–41. https://doi.org/10.1161/ATVBAHA.110.207316 PMID: 20508205
34. Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in
human disease. Free Radic Biol Med. 2004 Oct 15; 37(8):1097–104. https://doi.org/10.1016/j.
freeradbiomed.2004.07.008 PMID: 15451051
35. Wenzel P, Rossmann H, Müller C, Kossmann S, Oelze M, Schulz A, et al. Heme oxygenase-1 sup-
presses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial
hypertension in mice and humans. Eur Heart J. 2015 Dec 21; 36(48):3437–46. https://doi.org/10.1093/
eurheartj/ehv544 PMID: 26516175
36. Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD. Repeat transduction in the mouse lung by
using adeno-associated virus vectors with different serotypes. J Virol. 2000 Feb; 74(3):1524–32.
https://doi.org/10.1128/jvi.74.3.1524-1532.2000 PMID: 10627564
37. Li P, Li J, Li M, Gong J, He K. An efficient method to isolate and culture mouse Kupffer cells. Immunol
Lett. 2014 Apr; 158(1–2):52–6. https://doi.org/10.1016/j.imlet.2013.12.002 PMID: 24333337
38. Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, et al. Differential Ly-6C expres-
sion identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver
fibrosis. Proc Natl Acad Sci. 2012 Nov 13; 109(46):E3186–95. https://doi.org/10.1073/pnas.
1119964109 PMID: 23100531
39. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int Off J Int
Assoc Study Liver. 2006 Dec; 26(10):1175–86.
40. Kinoshita M, Uchida T, Sato A, Nakashima M, Nakashima H, Shono S, et al. Characterization of two F4/
80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol. 2010 Nov; 53
(5):903–10. https://doi.org/10.1016/j.jhep.2010.04.037 PMID: 20739085
41. Movita D, Kreefft K, Biesta P, van Oudenaren A, Leenen PJM, Janssen HLA, et al. Kupffer cells express
a unique combination of phenotypic and functional characteristics compared with splenic and peritoneal
macrophages. J Leukoc Biol. 2012 Oct; 92(4):723–33. https://doi.org/10.1189/jlb.1111566 PMID:
22685319
42. Kuranda K, Jean-Alphonse P, Leborgne C, Hardet R, Collaud F, Marmier S, et al. Exposure to wild-type
AAV drives distinct capsid immunity profiles in humans. J Clin Invest. 2018 03; 128(12):5267–79.
https://doi.org/10.1172/JCI122372 PMID: 30352429
43. Shen S, Bryant KD, Brown SM, Randell SH, Asokan A. Terminal N-linked galactose is the primary
receptor for adeno-associated virus 9. J Biol Chem. 2011 Apr 15; 286(15):13532–40. https://doi.org/10.
1074/jbc.M110.210922 PMID: 21330365
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